Rongchang Pharmaceuticals, Ltd.
http://en.rongchang.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Rongchang Pharmaceuticals, Ltd.
Younger Females' Cancer Incidence Increases Significantly In China
Latest data show a worrying public health trend that remains the top health concern in China despite surging COVID infections.
Deals Shaping The Medical Industry, April 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- RemeGen, Ltd., Rongchang Pharmaceuticals, Ltd., Beijing Rongchang Medicine R&D Institute, Yantai Lida Pharmaceutical Co., Ltd, MabPlex International Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Rongchang Pharmaceuticals, Ltd.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice